Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cervical vagus nerve stimulation for treatment-resistant depression.

Linda L Carpenter1, Gerhard M Friehs, Lawrence H Price

  • 1Department of Psychiatry, Brown University Medical School, Butler Hospital, 345 Blackstone Boulevard, Providence, RI 02906, USA. Linda_Carpenter_MD@Brown.edu

Neurosurgery Clinics of North America
|July 15, 2003
PubMed
Summary

Vagus nerve stimulation (VNS) shows promise for treatment-resistant depression, with promising long-term results in open-label studies. However, short-term trials have not yet confirmed its antidepressant efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploration of NMDA and GABA receptor-mediated plasticity induced by 10-Hz repetitive transcranial magnetic stimulation.

Translational psychiatry·2026
Same author

Social Needs Analysis in a Transcranial Magnetic Stimulation Patient Cohort with Major Depressive Disorder.

Rhode Island medical journal (2013)·2026
Same author

Intermittent theta burst stimulation for attention deficit hyperactivity disorder.

Brain stimulation·2026
Same author

When to Consider Transcranial Magnetic Stimulation for Youth With Depression Given Promising Data on Effectiveness-Authors' Reply.

JAACAP open·2026
Same author

Transient frontal spectral events from EEG predict antidepressant response to sertraline in depression.

Journal of psychiatric research·2026
Same author

Transient frontal spectral events from EEG predict antidepressant response to sertraline in depression.

medRxiv : the preprint server for health sciences·2026

Area of Science:

  • Neuroscience
  • Psychiatry
  • Medical Devices

Background:

  • Vagus nerve stimulation (VNS) is an established adjunctive therapy for medication-resistant epilepsy.
  • The vagus nerve's afferent pathways to brain regions involved in mood regulation suggest potential psychiatric applications.
  • Previous open-label studies indicated positive outcomes for VNS in treatment-resistant depression.

Purpose of the Study:

  • To evaluate the efficacy of VNS as a treatment for major depressive disorder.
  • To explore the long-term effectiveness of VNS in patients with treatment-resistant depression.
  • To investigate the potential role of VNS in psychiatric treatment modalities.

Main Methods:

  • Review of existing animal and human studies on VNS and its neural pathways.

Related Experiment Videos

  • Analysis of open-label study data for patients with treatment-resistant depression, focusing on long-term follow-up.
  • Consideration of results from a recent double-blind, sham-controlled study on short-term VNS treatment.

    • Main Results:

    • Open-label studies suggest promising long-term efficacy (1-2 years) of VNS for treatment-resistant depression.
    • A recent short-term (10 weeks) double-blind study did not show VNS to be superior to sham treatment.
    • Established safety and efficacy of VNS for epilepsy provides a foundation for further psychiatric research.

    Conclusions:

    • While VNS shows potential for treatment-resistant depression, its antidepressant efficacy is not yet definitively established.
    • Longer-term data and dose-response information are needed to clarify VNS's role in treating major depression.
    • Further research is warranted to determine the optimal use of VNS in psychiatric therapeutics.